NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £4,108,145,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 7 Apr 2025 |
| Procedure | open |
| OCID | ocds-h6vhtk-04e273 |
Awards (21)
This procurement was awarded to 21 suppliers. Values shown are per-award; the notice total is £4,108,145,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | · | · | active |
| Accord-UK Ltd shared | · | · | active |
| Alexion Pharmaceuticals shared | · | · | active |
| Amgen Ltd shared | · | · | active |
| Biogen shared | · | · | active |
| Celltrion Healthcare United Kingdom Limited shared | · | · | active |
| CuraTeQ Biologics s.r.o. shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Fresenius Kabi Limited shared | · | · | active |
| GlaxoSmithKline UK Limited shared | · | · | active |
| Janssen-Cilag Ltd shared | · | · | active |
| Organon Pharmaceuticals UK Ltd shared | · | · | active |
| Orifarm UK shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| Roche Products Ltd shared | · | · | active |
| Samsung Bioepis UK Ltd shared | · | · | active |
| Sandoz Ltd shared | · | · | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | · | · | active |
| Takeda UK Ltd shared | · | · | active |
| Thornton and Ross Ltd shared | · | · | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026
documents
- https://www.contractsfinder.service.gov.uk/Notice/8c603c5e-25d4-4ab4-8bb9-504458a54727 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/1688a671-4dfd-4480-bf73-c44d3a8e66aa
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2edeaa5f-49c9-4731-940a-ce510688056e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/500d0357-4e34-49e9-8f49-c1fe42ca194a
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/508b8d94-ee62-43ad-a938-d8fe3d4eb211
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/81318c8d-6877-4411-ac69-1ef3f4b338bd
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/83591f74-3c5c-4b30-ae8e-8c83aca3f6b3
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/85742564-f360-483e-8942-367e0c6afb0f
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8fa3ba33-e9d7-481f-a205-40e5b3c1a256
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/a3d30f4c-b6a4-4318-96f3-4f244e2b992c
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ae998b4a-8561-4fdd-ad28-94a82e109ed7
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/b757934f-8cb0-4393-942d-c7f7af2826cb
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c86b9b72-226e-4f9c-8e0e-54a326f9bb72
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/e5189dcb-18c5-4ed5-bc6f-09ba3312878d
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/e6f16247-d34d-4535-a6b3-c627f0bdf10e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f11397c9-5736-4cb9-9c8a-884fec6a3951
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f6f94dd0-9fcd-46e3-afd5-6bb2619b215f
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/fe801f8a-52d4-4ab1-86f5-d1df6ee37cc7
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Feb 2025 | Contract notice (F02) | Earlier regulations | 005287-2025 |
| 17 Feb 2025 | Tender (tender) | · | 8c603c5e-25d4-4ab4-8bb9-504458a54727-826898 |
| 29 Jul 2025 | Contract award notice (F03) | Earlier regulations | 043951-2025 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.